SCHEMBL22018172

SCHEMBL22018172

O=C(Nc1cnn2cccc2c1-c1ccccccccc1)c1ccccccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.52
TDO2 P48775 1/20 0.52
EPHB3 P54753 7/20 0.50
RIPK2 O43353 1/20 0.47
LCK P06239 1/20 0.47
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
KDR P35968 1/20 0.44
LMNA P02545 2/20 0.44
KDM4E B2RXH2 2/20 0.44
IRAK4 Q9NWZ3 1/20 0.44
HTT P42858 1/20 0.44
TP53 P04637 1/20 0.44
HDAC3 O15379 1/20 0.43
MAPK1 P28482 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC2 Q92769 1/20 0.43
MAPT P10636 2/20 0.43
ABCG2 Q9UNQ0 1/20 0.43
ALDH1A1 P00352 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18399564 0.78 HDAC3 (0.48) NPC1RAB9AKDM4EHDAC3HDAC1
SCHEMBL24832264 0.78 HDAC3 (0.48) NPC1RAB9AKDM4EHDAC3HDAC1
SCHEMBL22018175 0.75 CAMKK1 (0.46) EPHB3RIPK2LCKNPC1RAB9A
SCHEMBL16180212 0.73 IRAK4 (0.60) IDO1TDO2KDRLMNAIRAK4
SCHEMBL21436533 0.71 EPHB3 (0.63) EPHB3RIPK2LCKNPC1RAB9A
SCHEMBL18399563 0.69 MAP4K4 (0.43) EPHB3NPC1RAB9ALMNAKDM4E
SCHEMBL18378854 0.69 IDO1 (1.00) IDO1TDO2NPC1RAB9AKDR
SCHEMBL30009953 0.68 EPHB3 (0.63) EPHB3RIPK2LCKNPC1RAB9A
SCHEMBL25270859 0.68 IDO1 (0.45) IDO1TDO2NPC1RAB9AKDR
SCHEMBL27625287 0.67 HDAC2 (0.70) NPC1RAB9ATP53HDAC3MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10828290-B2 Thiazolecarboxamides and pyridinecarboxamide compounds useful as pim kinase inhibitors INCYTE CORPORATION (US) 2020-11-10 US disclosed
US-20200155527-A1 THIAZOLECARBOXAMIDES AND PYRIDINECARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS INCYTE HOLDINGS CORPORATION 2020-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200155527-A1 THIAZOLECARBOXAMIDES AND PYRIDINECARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS PIM2, PIM1, PIM3 IDO1 2199/4885TDO2 2328/4885EPHB3 4255/4885
US-10828290-B2 Thiazolecarboxamides and pyridinecarboxamide compounds useful as pim kinase inhibitors PIM2, PIM1, PIM3 IDO1 2199/4885TDO2 2328/4885EPHB3 4255/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.